1. Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS.
- Author
-
Arrieta-Bolaños E, van der Burg LLJ, Gedde-Dahl T, Robin M, Salmenniemi U, Kröger N, Yakoub-Agha I, Huynh A, Crawley C, Deconinck E, Bulabois CE, Forcade E, Tholouli E, van der Hem JGK, van Balen P, Hoogenboom JD, de Wreede LC, Malard F, Ruggeri A, and Fleischhauer K
- Subjects
- Humans, Male, Graft vs Host Disease immunology, Histocompatibility Testing methods, Female, Middle Aged, Adult, Leukemia immunology, Acute Disease, Aged, Myelodysplastic Syndromes therapy, Hematopoietic Stem Cell Transplantation, HLA-DP Antigens genetics
- Abstract
Abstract: HLA-DP permissive mismatches can be assigned a direction according to their immunopeptidome divergence across core and noncore subsets. Noncore permissive graft-versus-host mismatches show significantly reduced risks of relapse without increased nonrelapse mortality compared with allele-matched pairs., (© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.)
- Published
- 2024
- Full Text
- View/download PDF